Exact Sciences Reports Q4 Operating Loss of $82.595 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 13 2026
0mins
Source: moomoo
- Financial Performance: Exact Sciences reported a Q4 income from operations of USD 82.595 million.
- Company Overview: Exact Sciences is focused on advancing cancer diagnostics and treatment solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
